NEW YORK, Aug. 12, 2020 /PRNewswire/ -- As the race to find
a vaccine for the coronavirus continues, and news out of
Russia hints at a possible
COVID-19 vaccination win, ValuePenguin wanted to know how the
American people view vaccinations and whether or not they'd get one
if it became available.
We asked individuals their thoughts on effectiveness, how
protected they would feel, and if they would eventually feel
comfortable returning to work once a vaccination for coronavirus
had been produced. This is what we found:
Key findings:
- 79% of Americans are considering getting the coronavirus
vaccine once it's available to the public.
- 36% of individuals will get a COVID-19 vaccination as soon as
it's available; however, 42% say they'll wait at least a week
before being vaccinated
- Nearly half (45%) of parents said their child will definitely
receive the coronavirus vaccine.
- 51% of consumers believe K–12 public schools should require all
children to receive the coronavirus vaccine once it's available,
and 49% think offices should require the same of employees.
- Nearly 4 in 10 respondents said they're more likely to get a
flu shot this year because of the coronavirus. However, 12% said
they're actually less likely.
View full report: Survey: Americans Consider Coronavirus
Vaccination
About ValuePenguin.com: ValuePenguin.com, part of
LendingTree (NASDAQ: TREE), is a personal finance website that
conducts in-depth research and provides objective analysis to help
guide consumers to the best financial decisions. ValuePenguin
focuses on value, assessing whether the return of a particular
decision is worth the cost or risk of that option, and how this
stacks up with the other possible choices they may have. For more
information, please visit www.valuepenguin.com, like our Facebook
page, or follow us on Twitter @ValuePenguin.
Media Contact:
Nadia
Gonzalez (Mrs.)
Nadia@LendingTreeNews.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/only-79-of-americans-considering-getting-coronavirus-vaccine-according-to-valuepenguincom-survey-301111189.html
SOURCE ValuePenguin.com